GOSS GOSSAMER BIO INC
2026Q1 · CUSIP 38341P102 · Sector: Healthcare & Biotech
Fading · Price holds, watch
Holders
183
Δ holders QoQ
-12
Breadth percentile
Top 88%
Whale holders
95
Δ whales
-4
Inst. holding value
$69M
New positions
46
Closed positions
58
Price momentum (1Q)
—
Put / Call
4/11
Breadth history (34 quarters)
Past Lit Events & Aftermath 7 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q4 | Top 17% | -91.0% | — |
| 2025Q3 | Top 7% | -29.4% | -92.8% |
| 2025Q1 | Top 16% | +76.1% | +174.3% |
| 2022Q3 | Top 2% | -76.1% | -83.4% |
| 2021Q3 | Top 17% | -23.5% | -34.2% |
| 2020Q3 | Top 17% | +14.9% | -0.9% |
| 2020Q1 | Top 12% | -5.5% | -39.1% |
Options Sentiment
Put holders
4
QoQ: -6
Call holders
11
QoQ: -2
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.79
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
-55.4%
Net margin
-324.8%
ROE
—
Debt ratio
—
FCF (TTM)
-$170M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.